PAGITANE Drug Patent Profile
✉ Email this page to a colleague
When do Pagitane patents expire, and what generic alternatives are available?
Pagitane is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in PAGITANE is cycrimine hydrochloride. Additional details are available on the cycrimine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PAGITANE?
- What are the global sales for PAGITANE?
- What is Average Wholesale Price for PAGITANE?
Summary for PAGITANE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 24 |
Patent Applications: | 58 |
DailyMed Link: | PAGITANE at DailyMed |
![PAGITANE drug patent expirations Drug patent expirations by year for PAGITANE](/p/graph/s/t/PAGITANE-patent-expirations.png)
US Patents and Regulatory Information for PAGITANE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | PAGITANE | cycrimine hydrochloride | TABLET;ORAL | 008951-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lilly | PAGITANE | cycrimine hydrochloride | TABLET;ORAL | 008951-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |